Protara Therapeutics Inc. – Filings and Transcripts

NASDAQ: TARA
Share price (6/23/26): $4.00
Market cap (6/23/26): $225 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 03/31/26 Q1

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

ended 03/31/25 Q1

Prospectuses and Registrations Filter

Prospectus supplement for primary offering

Shelf registration

Prospectus with selling stockholder info

Prospectus with selling stockholder info

Prospectus with selling stockholder info

Ownership Filter

Solomon Michael Edward

News Filter

Shareholder Vote Results

Announces First Quarter 2026 Financial Results and Provides a Business Update

Material Disclosure

Announces Fourth Quarter and Full Year 2025 Financial Results and Provides a Business Update

TARA-002 Demonstrates 68% Complete Response Rate at Six Months in BCG-Unresponsive Non-Muscle Invasive Bladder Cancer

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Preliminary proxy

Additional info about upcoming vote

Definitive proxy

Other Filter

Notice of effectiveness

Scanned paper annual report submission

Scanned paper annual report submission

Notice of effectiveness

Correspondence with the SEC